Profile
Full Name
Marker Therapeutics, Inc.Ticker Symbol
MRKRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 16, 2002Indexes
Not includedEmployees
8Key Details
Price
$1.03(0.00%)
Market cap
$11.03M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$6.59M(+99.06% YoY)
Annual EPS
-$1.19(-26.60% YoY)
PE ratio
-
Next earnings date
May 15, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Marker Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 1, 25 WBB Securities
Strong BuyMar 5, 25 Canaccord Genuity
BuyApr 30, 24 Ladenburg Thalmann
BuyFeb 17, 22 Roth Capital
NeutralMar 25, 21 Piper Sandler
OverweightMar 19, 21 Cantor Fitzgerald
OverweightMar 18, 21 Cantor Fitzgerald
OverweightMay 12, 20 Piper Sandler
NeutralNov 13, 19 Piper Jaffray
OverweightNov 13, 19 Janney Capital
BuyInstitutional Ownership
- What is the ticker symbol for Marker Therapeutics?
- Does Marker Therapeutics pay dividends?
- What sector is Marker Therapeutics in?
- What industry is Marker Therapeutics in?
- What country is Marker Therapeutics based in?
- When did Marker Therapeutics go public?
- Is Marker Therapeutics in the S&P 500?
- Is Marker Therapeutics in the NASDAQ 100?
- Is Marker Therapeutics in the Dow Jones?
- When was Marker Therapeutics's last earnings report?
- When does Marker Therapeutics report earnings?
- Should I buy Marker Therapeutics stock now?
What is the ticker symbol for Marker Therapeutics?
The ticker symbol for Marker Therapeutics is NASDAQ:MRKR
Does Marker Therapeutics pay dividends?
No, Marker Therapeutics does not pay dividends
What sector is Marker Therapeutics in?
Marker Therapeutics is in the Healthcare sector
What industry is Marker Therapeutics in?
Marker Therapeutics is in the Biotechnology industry
What country is Marker Therapeutics based in?
Marker Therapeutics is headquartered in United States
When did Marker Therapeutics go public?
Marker Therapeutics's initial public offering (IPO) was on July 16, 2002
Is Marker Therapeutics in the S&P 500?
No, Marker Therapeutics is not included in the S&P 500 index
Is Marker Therapeutics in the NASDAQ 100?
No, Marker Therapeutics is not included in the NASDAQ 100 index
Is Marker Therapeutics in the Dow Jones?
No, Marker Therapeutics is not included in the Dow Jones index
When was Marker Therapeutics's last earnings report?
Marker Therapeutics's most recent earnings report was on Mar 31, 2025
When does Marker Therapeutics report earnings?
The next expected earnings date for Marker Therapeutics is May 15, 2025
Should I buy Marker Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions